This MedLibrary.org supplementary page on ATC code L01 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
To comply with Wikipedia's lead section guidelines, the introduction of this article may need to be rewritten. Please discuss this issue on the talk page and read the layout guide to make sure the section will be inclusive of all essential details. |
A section of the Anatomical Therapeutic Chemical Classification System.
L Antineoplastic and immunomodulating agents
Contents |
L01A Alkylating agents
L01AA Nitrogen mustard analogues
- L01AA01 Cyclophosphamide
- L01AA02 Chlorambucil
- L01AA03 Melphalan
- L01AA05 Chlormethine
- L01AA06 Ifosfamide
- L01AA07 Trofosfamide
- L01AA08 Prednimustine
L01AB Alkyl sulfonates
- L01AB01 Busulfan
- L01AB02 Treosulfan
- L01AB03 Mannosulfan
L01AC Ethylene imines
- L01AC01 Thiotepa
- L01AC02 Triaziquone
- L01AC03 Carboquone
L01AD Nitrosoureas
- L01AD01 Carmustine
- L01AD02 Lomustine
- L01AD03 Semustine
- L01AD04 Streptozocin
- L01AD05 Fotemustine
- L01AD06 Nimustine
- L01AD07 Ranimustine
L01AG Epoxides
- L01AG01 Etoglucid
L01AX Other alkylating agents
- L01AX01 Mitobronitol
- L01AX02 Pipobroman
- L01AX03 Temozolomide
- L01AX04 Dacarbazine
L01B Antimetabolites
L01BA Folic acid analogues
- L01BA01 Methotrexate
- L01BA03 Raltitrexed
- L01BA04 Pemetrexed
L01BB Purine analogues
- L01BB02 Mercaptopurine
- L01BB03 Tioguanine
- L01BB04 Cladribine
- L01BB05 Fludarabine
- L01BB06 Clofarabine
L01BC Pyrimidine analogues
- L01BC01 Cytarabine
- L01BC02 Fluorouracil
- L01BC03 Tegafur
- L01BC04 Carmofur
- L01BC05 Gemcitabine
- L01BC06 Capecitabine
- L01BC52 Fluorouracil, combinations
- L01BC53 Tegafur, combinations
L01C Plant alkaloids and other natural products
L01CA Vinca alkaloids and analogues
- L01CA01 Vinblastine
- L01CA02 Vincristine
- L01CA03 Vindesine
- L01CA04 Vinorelbine
L01CB Podophyllotoxin derivatives
- L01CB01 Etoposide
- L01CB02 Teniposide
L01CC Colchicine derivatives
- L01CC01 Demecolcine
L01CD Taxanes
- L01CD01 Paclitaxel
- L01CD02 Docetaxel
L01CX Other plant alkaloids and natural products
- L01CX01 Trabectedin
L01D Cytotoxic antibiotics and related substances
L01DA Actinomycines
- L01DA01 Dactinomycin
L01DB Anthracyclines and related substances
- L01DB01 Doxorubicin
- L01DB02 Daunorubicin
- L01DB03 Epirubicin
- L01DB04 Aclarubicin
- L01DB05 Zorubicin
- L01DB06 Idarubicin
- L01DB07 Mitoxantrone
- L01DB08 Pirarubicin
- L01DB09 Valrubicin
L01DC Other cytotoxic antibiotics
- L01DC01 Bleomycin
- L01DC02 Plicamycin
- L01DC03 Mitomycin
L01X Other antineoplastic agents
L01XA Platinum compounds
- L01XA01 Cisplatin
- L01XA02 Carboplatin
- L01XA03 Oxaliplatin
L01XB Methylhydrazines
- L01XB01 Procarbazine
L01XC Monoclonal antibodies
- L01XC01 Edrecolomab
- L01XC02 Rituximab
- L01XC03 Trastuzumab
- L01XC04 Alemtuzumab
- L01XC05 Gemtuzumab
- L01XC06 Cetuximab
- L01XC07 Bevacizumab
- L01XC08 Panitumumab
L01XD Sensitizers used in Photodynamic/Radiation therapy
- L01XD01 Porfimer sodium
- L01XD02 Verteporfin
- L01XD03 Methyl aminolevulinate
- L01XD04 Aminolevulinic acid
- L01XD05 Temoporfin
- L01XD06 Efaproxiral
L01XE Protein kinase inhibitors
- L01XE01 Imatinib
- L01XE02 Gefitinib
- L01XE03 Erlotinib
- L01XE04 Sunitinib
- L01XE05 Sorafenib
- L01XE06 Dasatinib
L01XX Other antineoplastic agents
- L01XX01 Amsacrine
- L01XX02 Asparaginase
- L01XX03 Altretamine
- L01XX05 Hydroxycarbamide
- L01XX07 Lonidamine
- L01XX08 Pentostatin
- L01XX09 Miltefosine
- L01XX10 Masoprocol
- L01XX11 Estramustine
- L01XX14 Tretinoin
- L01XX16 Mitoguazone
- L01XX17 Topotecan
- L01XX18 Tiazofurine
- L01XX19 Irinotecan
- L01XX22 Alitretinoin
- L01XX23 Mitotane
- L01XX24 Pegaspargase
- L01XX25 Bexarotene
- L01XX27 Arsenic trioxide
- L01XX28 Imatinib
- L01XX29 Denileukin diftitox
- L01XX31 Gefitinib
- L01XX32 Bortezomib
- L01XX33 Celecoxib
- L01XX34 Erlotinib
- L01XX35 Anagrelide
L01XY Combinations of antineoplastic agents
Wikipedia content modification information:
- This page was last modified on 12 June 2008, at 19:49.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "ATC code L01".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.